News · Oncology
1,499 stories
Jun 5, 26Pharma is betting big on PD-1/VEGF bispecifics. But are companies chasing the wrong target?
Jun 4, 26HHS confirms Americans with high-risk Ebola exposures will have access to experimental therapy
Jun 4, 26STAT+: Otsuka kidney drug slowed loss of function, but less than expected, in late-stage trial
Jun 3, 26STAT+: Alnylam to partner with Inceptive Nucleics for AI foundation models for RNAi therapeutics